Corient Private Wealth
LENZ

Corient Private Wealth’s LENZ Therapeutics LENZ Stock Holding History

Corient Private Wealth’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$341K Buy
+37,259
New +$523K ﹤0.01% 2251
2025
Q4 		– Sell
-28,259
Closed -$1.32M – 2861
2025
Q3 		$1.32M Buy
+28,259
New +$1.04M ﹤0.01% 1285

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Corient Private Wealth's LENZ Position: Q1 2026 in Review

Corient Private Wealth opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 37,259 shares worth $341K. The stake represents ﹤0.01% of the portfolio and ranks #2251 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in LENZ as recently as Q3 2025.

Corient Private Wealth first reported a position in LENZ in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.32M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Corient Private Wealth held 37,259 shares of LENZ Therapeutics worth $341K as of Q1 2026.
  • LENZ Therapeutics was a new Corient Private Wealth position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2251 holding.
  • Corient Private Wealth first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Corient Private Wealth's LENZ Therapeutics position peaked at $1.32M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.